Helius Medical Technologies, Inc. (HSDT) Tops Q2 EPS by 15c

Helius Medical Technologies, Inc. (NASDAQ: HSDT) reported Q2 EPS of ($0.97), $0.15 better than the analyst estimate of ($1.12). Revenue for the quarter came in at $119 thousand versus the consensus estimate of $360 thousand.

For earnings history and earnings-related data on Helius Medical Technologies, Inc. (HSDT) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c